至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Characterization of Diabetogenic CD8+ T Cells: IMMUNE THERAPY WITH METABOLIC BLOCKADE.

J. Biol. Chem.. 2016-07; 
GaryuJustin W,UdumanMohamed,StewartAlex,RuiJinxiu,DengSongyan,ShensonJared,StaronMatt M,KaechSusan M,KleinsteinSteven H,HeroldKev
Products/Services Used Details Operation
Peptide Synthesis … and heavy and light chain proteins were refolded in a solution containing a high concentration of NRP-V7 (KYNKANVFL) mimotope, negative control peptide TUM (KYQAVTTTL), or in mice infected with LCMV, Gp33, and Gp276 peptides (Genscript, Piscataway, NJ) as … Get A Quote

摘要

Type 1 diabetes mellitus is caused by the killing of insulin-producing β cells by CD8+T cells. The disease progression, which is chronic, does not follow a course like responses to conventional antigens such as viruses, but accelerates as glucose tolerance deteriorates. To identify the unique features of the autoimmune effectors that may explain this behavior, we analyzed diabetogenic CD8+ T cells that recognize a peptide from the diabetes antigen IGRP (NRP-V7-reactive) in prediabetic NOD mice and compared them to others that shared their phenotype (CD44(+)CD62L(lo)PD-1(+)CXCR3(+)) but negative for diabetes antigen tetramers and to LCMV (lymphocytic choriomeningitis)-reactive CD8+ T cells. There was an... More

关键词

T-cell,autoimmunity,beta cell (B-cell),immunology,type 1 diab